BALCHEM CORP
About BALCHEM CORP
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.0B
- Net income
- $154.8M
- Total assets
- $1.7B
- Market cap
- $5.1B
- Gross margin
- 35.7%
- Operating margin
- 20.2%
- Net margin
- 14.9%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.0B
- Cost of revenue
- $666.5M
- Gross profit
- $370.6M
- Operating expenses
- $161.3M
- Operating income
- $209.3M
- Income tax
- $44.2M
- Net income
- $154.8M
- EPS (basic)
- $4.80
- EPS (diluted)
- $4.75
Balance sheet
- Total assets
- $1.7B
- Current assets
- $365.6M
- Total liabilities
- $428.8M
- Current liabilities
- $176.4M
- Shareholders’ equity
- $1.3B
Cash flow
- Operating cash flow
- $216.6M
- Investing cash flow
- -$43.9M
- Financing cash flow
- -$152.8M
- Net cash flow
- $25.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $5.1B
- P/E ratio
- 34.0
- EPS (diluted)
- $4.75
- Dividend yield
- 0.59%
- Shares outstanding
- 31.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 3, 1986
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $154.8M in FY2025.
- Revenue grew 30% from FY2021 to FY2025.
- Gross margin of 35.7%, net margin 14.9%.
- Trading 12% below its 52-week high.
- Pays a dividend yielding about 0.59% annually.
- Valued at a price-to-earnings (P/E) ratio of 34.0.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review BALCHEM CORP.
Write a review
News about BALCHEM CORP
News & sentiment via Polygon.io
